Invention Grant
US08722700B2 CCI-779 formulations for parenteral administration 有权
用于肠胃外给药的CCI-779制剂

CCI-779 formulations for parenteral administration
Abstract:
This invention provides CCI-779 cosolvent concentrates which are useful in preparing a parenteral formulation of rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid (CCI-779) following admixture with a diluent.
Public/Granted literature
Information query
Patent Agency Ranking
0/0